Filter your search
Cancer diagnosis and treatment represents a significant expenditure in developed healthcare systems. Cancer screening is performed through routine tests such as complete blood counts (CBCs), differentials, and protein markers. However, the global oncology diagnostics market is quickly evolving past established markers and companion diagnostics in the United States, Europe and Japan. Targeted cancer therapies are finding significant demand in emerging middle-income countries such as China and new technologies such as liquid biopsies, next-generation sequencing (NGS) and novel hybridization assays are being developed for cancer detection and diagnosis. Kalorama Information market research covers cancer diagnostics from multiple angles of diagnostic technology and regional demand.
- This Kalorama Information In Vitro Diagnostics (IVD) Market Bundle represents three reports, as published in 2015. These reports, representing over 2,000 pages of market information, delve into some of the fastest-growing and most critical areas of clinical diagnostics: cancer diagnostics, molecular assays and systems, and infectious disease tests. Together, these three in vitro diagnostic areas […]January 22, 2016$3,360.00 – $6,720.00IVD in India IVD in India provides analysis of the Indian IVD industry and presents projections to 2025, featuring estimates of the total opportunity and its component sectors, including: total IVD revenues in India, 2015-2025, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2015, IVD revenues in […]January 6, 2016$499.00 – $1,000.00Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. […]October 26, 2015The World Market for Cancer Diagnostics, 2014-2019, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays) Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring […]September 11, 2015Histology and cytology tests are essential for identifying cancer, inherited, infectious disease and other diseases. This report focuses on tissue and cell diagnostic assays and technologies, providing the world markets for histology and cytology diagnostics for the current market and forecasted to 2018. All of the technologies and applications discussed in this report share the […]November 20, 2014Diagnostic Markets for Women’s Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing) Kalorama Information’s report on Women’s Health Diagnostic Markets takes a solid look at the current and developing world markets for key diagnostic tests aimed at the health of women. The report presents market […]October 30, 2014$995.00 – $1,990.00The World Market for Flow Cytometry in IVD Applications Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic instruments for cancer diagnostics, but their newer clinical applications included the commercialization and refinement of HIV testing and monitoring through CD4/CD8 counts. […]June 16, 2014$1,995.00 – $3,990.00The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market. Most recently the U.S. IVD market weathered interrupted lab and […]March 18, 2014$995.00 – $1,990.00Full coverage of the IVD market in Mexico, including important IVD segments.December 16, 2013$1,995.00 – $4,000.00The World Market for Hematology Used for both critical and routine testing, hematology is a central part of IVD. CBCs contribute to the general assessment of health for patients during regular check-ups. Conditions such as anemia, other blood disorders, infection, allergy, iron and vitamin deficiencies are easily diagnosed through a CBC. This report, authored by […]November 22, 2013